Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tokyo-Based Terumo Constructs New Production Facility Amid Strong Catheter Demand 

This article was originally published in PharmAsia News

Executive Summary

Tokyo-based Terumo Corp will construct a new catheter production facility in Fujinomiya, Shizuoka Prefecture. Terumo's catheter products are used for heart disease treatments, and its guide wire accounts for 30 percent of the worldwide market share. Terumo's blood vessel balloon catheters and stents are directly contributing to the company's global expansion. Less painful compared to surgery, demand for catheter treatment is estimated to be strong around the world. The new facility will start producing from Fall 2009 and will supply the U.S., European and Asian markets. (Click here for more - Japanese language

You may also be interested in...



FDA Approves Medtronic’s Abre Venous Stent

The approval is based on the results ABRE clinical study, which showed the stent improved patency iliofemoral veins in 88% of cases with a 2% rate of major adverse events.

AbbVie Investors Look For Stabilizing Botox Revenues In Q3 Financials

Reporting its first full quarter of financials since merging with Allergan, AbbVie will be scrutinized for whether its optimistic talk of a quick Botox rebound actually happened.

COVID-19 Could Drive UK OTC Rises

Generic OTC paracetamol and ibuprofen pack prices are gradually returning to pre-COVID levels, according to market analysts Wavedata. But a second wave could drive prices back up again.

UsernamePublicRestriction

Register

LL1134409

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel